In addition to canonical RTK signalling, nuclear import of FGFR1 has been reported in a number of physiological contexts [16], including in breast and pancreatic cancers, where it can promote cancer cell invasion and therapy resistance [17, 18]. The gene discussed is FGFR1; the disease is familial pancreatic carcinoma.